U.S. SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549


                                    FORM F-X

           APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING


A.   Name of issuer or person filing ("Filer"):

                                 NEUROCHEM INC.

B.   (1)  This is [check one]:

          [X]  an original filing for the Filer

          [ ]  an amended filing for the Filer

     (2)  Check the following box if you are filing the Form F-X in paper in
          accordance with Regulation S-T Rule 101(b)(9) [ ]

     (3)  A filer may also file the Form F-X in paper under a hardship exemption
          provided by Regulation S-T Rule 201 or 202 (17 CFR 232.201 or
          232.202). When submitting the Form F-X in paper under a hardship
          exemption, a filer must provide the legend required by Regulation S-T
          Rule 201(a)(2) or 202(c) (17 CFR 232.201(a)(2) or 232.202(c)) on the
          cover page of the Form F-X. '

C.   Identify the filing in conjunction with which this Form being filed:

                  Name of registrant:  Neurochem Inc.
                  Form type:  Form F-10
                  File Number (if known):
                  Filed by:  Neurochem Inc.
                  Date Filed (if filed concurrently, so indicate): August 20th,
                  2003 (concurrently herewith)

D.   The Filer is incorporated or organized under the laws of:

                                     Canada

     and has its principal place of business at:

                          7220 Frederick-Banting Street
                      Saint-Laurent, Quebec H4S 2A1, Canada
                                 (514) 337-4646

E.   The Filer designates and appoints:

                              CT Corporation System
                                111 Eighth Avenue
                               New York, NY 10011
                                 (212) 894-8400






     ("Agent") as the agent of the Filer upon whom may be served any process,
pleadings, subpoenas, or other papers in:


     (a)  any investigation or administrative proceeding conducted by the
          Commission; and

     (b)  any civil suit or action brought against the Filer or to which the
          Filer has been joined as defendant or respondent, in any appropriate
          court in any place subject to the jurisdiction of any state or of the
          United States or of any of its territories or possessions or of the
          District of Columbia, where the investigation, proceeding or cause of
          action arises out of or related to or concerns (i) any offering made
          or purported to be made in connection with the securities registered
          or qualified by the Filer on Form F-10 on August 20th, 2003 or any
          purchases or sales of any security in connection therewith; (ii) the
          securities in relation to which the obligation to file an annual
          report on Form 40-F arises, or any purchases or sales of such
          securities; (iii) any tender offer for the securities of a Canadian
          issuer with respect to which filings are made by the Filer with the
          Commission on Schedule 13E-4F, 14D-1F or 14D-9F; or (iv) the
          securities in relation to which the Filer acts as trustee pursuant to
          an exemption under Rule 10a-5 under the Trust Indenture Act of 1939.
          The Filer stipulates and agrees that any such civil suit or action or
          administrative proceeding may be commenced by the service of process
          upon, and that service of an administrative subpoena shall be effected
          by service upon such agent for service of process, and that service as
          aforesaid shall be taken and held in all courts and administrative
          tribunals to be valid and binding as if personal service thereof had
          been made.


     F.   Each person filing this Form in connection with:


          (a)  the use of Form F-9, F-10, 40-F, or SB-2 or Schedule 13K-4F,
               14D-1F or 14D-9F stipulates and agrees to appoint a successor
               agent for service of process and file an amended Form F-X if the
               Filer discharges the Agent or the Agent is unwilling or unable to
               accept service on behalf of the Filer at any time until six years
               have elapsed from the date the issuer of the securities to which
               such Forms and Schedules relate has ceased reporting under the
               Exchange Act;

          (b)  the use of Form F-8, Form F-80 or Form CB stipulates and agrees
               to appoint a successor agent for service of process and file an
               amended Form F-X if the Filer discharges the Agent or the Agent
               is unwilling or unable to accept service on behalf of the Filer
               at any time until six years have elapsed from the effective date
               of the latest Amendment to such Form F-8, Form F-80 or Form CB;

          (c)  its status as trustee with respect to securities registered on
               Form F-7, F-8, F-9, F-10, F-80, or SB-2 stipulates and agrees to
               appoint a successor agent for service of process and file an
               amended Form F-X if the Filer discharges the Agent or the Agent
               is unwilling or unable to accept service on behalf of the Filer
               at any time during which any of the securities subject to the
               indenture remain outstanding; and

                                       2


          (d)  the use of Form 1-A or other Commission form for an offering
               pursuant to Regulation A stipulates and agrees to appoint a
               successor agent for service of process and file an amended Form
               F-X if the Filer discharges the Agent or the Agent is unwilling
               or unable to accept service on behalf of the Filer at any time
               until six years have elapsed from the date of the last sale of
               securities in reliance upon the Regulation A exemption.

          Each filer further undertakes to advise the Commission promptly of any
          change to the Agent's name and address during the applicable period by
          amendment of this Form, referencing the file number of the relevant
          form in conjunction with which the amendment is being filed.

     G.   Each person filing this Form, other than a trustee filing in
          accordance with General Instruction I.(e) of this Form, undertakes to
          make available, in person or by telephone, representatives to respond
          to inquiries made by the Commission staff, and to furnish promptly,
          when requested to do so by the Commission staff, information relating
          to: the Forms, Schedules, and offering statements described in General
          Instructions I.(a), I.(b), I.(c), I.(d) and I.(f) of this Form, as
          applicable; the securities to which such Forms, Schedules and offering
          statements relate; and the transactions in such securities.




                                       3





         The Filer certifies that it has duly caused this power of attorney,
consent, stipulation and agreement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City Saint-Laurent, Province of
Quebec, Country of Canada, this 19th day of August, 2003.


                                 NEUROCHEM INC.



                                 By: /s/ FRANCESCO BELLINI
                                     -------------------------------------------
                                      Name:  Francesco Bellini, Ph.D.
                                      Title: Chairman of the Board and
                                             Chief Executive Officer




This statement has been signed by the following person in the capacity and on
the date indicated.

CT Corporation System, as Agent for Service of Process



By:  /s/ JONATHAN R. GIDDINGS
     ---------------------------------------
      Name:  Jonathan R. Giddings
      Title: Assistant Secretary

Date: August 19th, 2003






                                       4